Loading...
NPI 1780655258 · Metairie, LA · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Bruce Germer is a ophthalmology physician provider located in Metairie, Louisiana. This profile covers 16 Medicare and 7 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Bruce Germer |
| Address | 3530 Houma Blvd |
| City | Metairie |
| State | LA |
| ZIP | 70006 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | January 31, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.7M |
| Medicaid | $59.7K |
This provider’s revenue is heavily Medicare-weighted: reported lifetime Medicare revenue is $1.7M versus $59.7K from Medicaid, indicating the practice is effectively Medicare-centric in scale and payer mix rather than balanced across the two public programs. The Medicaid footprint exists but is small relative to Medicare, so payer-level trends and reimbursement changes in Medicare will have outsized impact on overall revenue.
Revenue concentration is high on both payers: the top three Medicare codes account for 77.8% of Medicare revenue and the top three Medicaid codes account for 68.6% of Medicaid revenue, signaling reliance on a short list of high-return services. That concentration means changes to utilization or reimbursement for those specific codes could materially affect total revenue.
The practice’s clinical profile is focused on intravitreal injections and posterior-segment retinal care. J2777 (faricimab) alone generates $1M and 61.6% of Medicare revenue, and other injection codes such as J0178 (aflibercept) and J2781 (pegcetacoplan) appear on the Medicare top list; paired with frequent retinal imaging codes (92250, 92134), this mix is consistent with a retina-oriented ophthalmology operation that performs high volumes of in-office drug administration and diagnostic imaging.
J2777 is a major Medicare revenue driver but is not an extreme outlier nationally: it generates $1M (61.6% of this provider’s Medicare revenue) and ranks #201 of 2039 providers nationally (90th percentile; typical, unremarkable volume for this code). By contrast some drug codes show more modest national standing—J0178 ranks #2626 of 3204 (18th percentile; typical, unremarkable volume) while J3490 sits near median range at #1091 of 2838 (61th percentile; typical, unremarkable volume)—indicating a mixed competitive position across different injectable products.
The provider is an outsized contributor of fundus photography services at the national Medicare level: 92250 produces $29.1K (1.7% of Medicare revenue) but ranks #182 of 25087 providers nationally (99th percentile; extreme outlier, far above typical national volume). Complementary imaging codes such as 92134 (93th percentile; typical, unremarkable volume) and 92285 (97th percentile; notably above typical national volume) further support a high-capacity retinal imaging operation.
Medicaid billing mirrors the Medicare pattern but at much smaller scale: Medicaid 92250 is the top Medicaid code with $16.8K (28.3% of Medicaid revenue) and ranks #73 of 211 in-state (65th percentile; typical, unremarkable volume), while 67028 contributes $15.4K (26.0% of Medicaid revenue) but ranks #44 of 53 in-state (17th percentile; typical, unremarkable volume). This shows the provider bills similar service types to Medicaid patients (imaging and intravitreal injections) but is less competitively dominant in-state for injections.
Operationally, the mix of high-volume in-office injectable drugs (notably faricimab/J2777) and extensive retinal imaging implies significant investment in drug handling, injection suites, and imaging equipment and staffing. That set-up supports retina-focused workflows and revenue capture from both drug-administering visits and multimodal diagnostic testing, but it also concentrates operational risk if drug utilization or imaging volumes shift.
The NPI tenure indicates a long-established practice footprint: NPI enumerated 2006-01-31 (~20 years ago). Combined with the concentrated-service profile and several very high national percentiles for imaging codes, the data suggest an experienced, retina-focused solo or small-group operator with entrenched Medicare business in Metairie, LA rather than a broad multispecialty outpatient practice.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 35,940 | $30 | $1M |
| J3490 | Unclassified drugs | 80 | $1,890 | $141.6K |
| J0178 | Injection, aflibercept, 1 mg | 190 | $690 | $132.1K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 830 | $120 | $99K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 720 | $100 | $70.4K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 950 | $60 | $60.9K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,240 | $30 | $34.8K |
| 92242 | The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He… | 170 | $180 | $29.5K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 1,120 | $30 | $29.1K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 260 | $90 | $22.4K |
Showing 1–10 of 16
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
16 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 39 | 50 | 300 | $680 | $371.5K |
| J2777 | 2 | 30 | 6,660 | $30 | $309.4K |
| J2781 | 3 | 10 | 830 | $120 | $86K |
| J3490 | 7 | 20 | 50 | $620 | $49.1K |
| 67028 | 16 | 70 | 410 | $80 | $44.3K |
| 92014 | 170 | 470 | 170 | $80 | $23.9K |
| 92242 | 2 | 10 | 90 | $180 | $18.5K |
| J7999 | 19 | 20 | 140 | $40 | $16.6K |
| 92012 | 9 | 350 | 100 | $60 | $11.7K |
| 92235 | 22 | 40 | 70 | $90 | $11.3K |
Showing 1–10 of 16
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 480 | $40 | $16.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 120 | $130 | $15.4K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 200 | $40 | $8.5K |
| J9035 | Injection, bevacizumab, 10 mg | 110 | $70 | $7.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 420 | $20 | $7.6K |
| 92226 | N/A | 170 | $10 | $2.2K |
| 92235 | The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken… | 10 | $70 | $990 |
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
7 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 44 | 50 | 470 | $60 | $95.8K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 145 | 260 | 330 | $30 | $41.7K |
| J9035 | Injection, bevacizumab, 10 mg | 24 | 40 | 240 | $30 | $34.1K |
| 92235 | The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken… | 18 | 20 | 200 | $30 | $21K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 73 | 130 | 490 | $10 | $19.4K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 73 | 210 | 200 | $20 | $17.5K |
| 92226 | N/A | 21 | 30 | 450 | $10 | $5.5K |
Other providers in the same ZIP code as Bruce Germer, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.